Stay updated on Sitravatinib for Metastatic Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Sitravatinib for Metastatic Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Sitravatinib for Metastatic Breast Cancer Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    - Revision: v3.3.4 added; Revision: v3.3.3 removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T02:14:15.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    31 days ago
    Change Detected
    Summary
    Added a 'Locations' section with a Texas site; the 'Texas Locations' label was removed. The footer policy link 'HHS Vulnerability Disclosure' was removed and the page revision updated from v3.3.2 to v3.3.3.
    Difference
    0.2%
    Check dated 2025-12-23T12:40:14.000Z thumbnail image
  5. Check
    52 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.3.2, replacing Revision: v3.3.1. This is a minor template/version update and does not modify study details or other user-facing content.
    Difference
    0.1%
    Check dated 2025-12-01T17:38:54.000Z thumbnail image
  6. Check
    59 days ago
    Change Detected
    Summary
    Revision updated from v3.2.0 to v3.3.1 on the page, with no other observable changes to study content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-24T14:48:12.000Z thumbnail image
  7. Check
    67 days ago
    Change Detected
    Summary
    Removed the banner about government funding-related information and potential delays; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-17T07:00:28.000Z thumbnail image
  8. Check
    81 days ago
    Change Detected
    Summary
    The changes are cosmetic UI/layout adjustments and minor wording changes; core trial details such as eligibility criteria, outcomes, and enrollment remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-03T01:24:02.000Z thumbnail image

Stay in the know with updates to Sitravatinib for Metastatic Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Sitravatinib for Metastatic Breast Cancer Clinical Trial page.